Depends on the product (juice, extract).
⏱ 2 min read
Bitter melon, also known as karela or cundeamor, is the fruit of Momordica charantia, a cucurbit cultivated in Asia, Africa, and the Caribbean that is used both as a food (cooked with spices to mitigate its characteristic bitter taste) and as a traditional remedy for glucose control; Ayurvedic and traditional Chinese medicine have prescribed it for centuries in conditions we would today recognize as prediabetes, type 2 diabetes, and metabolic syndrome, an indication that modern clinical research has partially confirmed, with a modest but replicable effect profile.
Several active compounds have been identified: charantin (a mixture of steroids with a hypoglycemic effect), polypeptide-p (a protein with some structural analogy to human insulin), vicine, and a group of cucurbitacins with insulin-mimetic activity and modulation of glucose uptake by muscle; this multiplicity of mechanisms explains why the whole extract appears more effective than any isolated component, and why products standardized to a single active principle give worse clinical results than the complete extract.
The indication with the best evidence is glycemic control in mild to moderate type 2 diabetes and in prediabetes: several randomized trials have shown modest reductions in fasting glucose and glycated hemoglobin (HbA1c) with doses of 1,000-2,000 milligrams daily of extract for 8-12 weeks, with effect sizes smaller than those of metformin but sufficient as an adjunct or as an option for people in very early stages who do not want or cannot tolerate pharmacological treatments.
A systematic review published in 2014 analyzed four clinical trials and concluded that the effect on HbA1c is real but modest (reductions of 0.2-0.5 points, comparable to some mild antidiabetic drugs but clearly inferior to metformin); methodological heterogeneity between studies and variability in extract standardization limit the strength of the conclusions, a common limitation in research on complex medicinal plants.
In metabolic syndrome, several small studies have shown improvements in lipid profile (modest reductions in triglycerides and LDL, modest increases in HDL) and in inflammatory markers; the effects are quantitatively smaller than those of statins or fibrates but consistent with a multifactorial metabolic modulation profile that could make sense as part of a comprehensive strategy in people with insulin resistance and mild dyslipidemia.
The doses studied range from 1,000 to 2,000 milligrams daily of dried fruit extract or from 50 to 100 milliliters of fresh juice, divided into two or three doses with meals; the effect on blood glucose appears gradually and requires several weeks to be evaluable; whole-fruit formulations appear to be more effective than those of isolated seeds or those standardized to a single active principle.
Generally well tolerated at moderate doses; the most frequent adverse effects are digestive discomfort (nausea, diarrhea, abdominal pain), especially with fresh juice; at high doses or with prolonged use it can cause hypoglycemia, especially in people taking pharmacological antidiabetic drugs (high caution with sulfonylureas and insulin); it is contraindicated in pregnancy (an abortifacient effect has been described in animal models and in traditional use) and breastfeeding, and should be used with caution in people with G6PD deficiency because of a theoretical risk of hemolysis with high doses of the seeds.
Information, not medical advice. Scientific evidence reflects the quality of the studies.